# Denosumab Safety Assessment in Multiple Observational Databases

> **NCT02520362** · — · COMPLETED · sponsor: **Amgen** · enrollment: 517991 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** denosumab
- **DRUG:** bisphosphonate

## Key facts

- **NCT ID:** NCT02520362
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-31
- **Primary completion:** 2023-07-21
- **Final completion:** 2023-07-21
- **Target enrollment:** 517991 (ACTUAL)
- **Last updated:** 2024-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02520362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02520362, "Denosumab Safety Assessment in Multiple Observational Databases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02520362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*